Cutler Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-900
Closed -$8K 4588
2022
Q3
$8K Buy
900
+600
+200% +$287K ﹤0.01% 3264
2022
Q2
$2K Sell
300
-5,700
-95% -$2.82M ﹤0.01% 4268
2022
Q1
$140K Buy
6,000
+5,000
+500% +$2.29M 0.01% 1448
2021
Q4
$84K Sell
1,000
-1,000
-50% -$421K ﹤0.01% 1989
2021
Q3
$39K Buy
+2,000
New +$760K ﹤0.01% 2721
2021
Q1
Sell
-6,000
Closed -$344K 5785
2020
Q4
$344K Hold
6,000
0.02% 806
2020
Q3
$144K Hold
6,000
0.01% 1098
2020
Q2
$186K Hold
6,000
0.01% 906
2020
Q1
$114K Sell
6,000
-1,200
-17% -$327K 0.01% 1267
2019
Q4
$355K Buy
7,200
+200
+3% +$55K 0.02% 573
2019
Q3
$156K Sell
7,000
-4,800
-41% -$1.32M 0.01% 821
2019
Q2
$243K Buy
11,800
+10,900
+1,211% +$2.98M 0.02% 607
2019
Q1
$4K Buy
+900
New +$260K ﹤0.01% 3024
2017
Q2
Sell
-2,500
Closed -$4K 6502
2017
Q1
$4K Sell
2,500
-8,800
-78% -$1.4M ﹤0.01% 4870
2016
Q4
$80K Buy
11,300
+3,300
+41% +$442K ﹤0.01% 2105
2016
Q3
$3K Sell
8,000
-800
-9% -$103K ﹤0.01% 5339
2016
Q2
$16K Buy
8,800
+2,800
+47% +$383K ﹤0.01% 3585
2016
Q1
$15K Hold
6,000
﹤0.01% 3584
2015
Q4
$32K Buy
+6,000
New +$827K ﹤0.01% 2913

Other funds holding ELV

Cutler Group's ELV Position: Q4 2022 in Review

Cutler Group sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 46 shares — an estimated $20K sold.

Cutler Group first reported a position in ELV in Q2 2016 and held it in 15 quarters. The position peaked at $1.76M in Q2 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Cutler Group reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 46 Elevance Health shares in Q4 2022, an estimated $20K.
  • Cutler Group first reported a position in Elevance Health in Q2 2016 and held it in 15 quarters.
  • Cutler Group's Elevance Health position peaked at $1.76M in Q2 2019.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.